Hood River Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Hood River Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-121,277	Closed	-$6.98M	–	98
2015 Q2	$6.98M	Buy	+121,277	New	+$7.71M	0.85%	50
2015 Q1	–	Sell	-120,185	Closed	-$7.42M	–	82
2014 Q4	$7.42M	Buy	120,185 +8,481	+8%	+$418K	0.94%	45
2014 Q3	$4.34M	Sell	111,704 -2,426	-2%	-$86K	0.6%	68
2014 Q2	$3.93M	Buy	+114,130	New	+$3.59M	0.53%	73

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Hood River Capital Management's IONS Position: Q3 2015 in Review

Hood River Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2015, closing a stake of 121,277 shares — an estimated $6.98M sold.

Hood River Capital Management first reported a position in IONS in Q2 2014 and held it in 4 quarters. The position peaked at $7.42M in Q4 2014. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

Hood River Capital Management reported no remaining Ionis Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Hood River Capital Management sold 121,277 Ionis Pharmaceuticals shares in Q3 2015, an estimated $6.98M.
Hood River Capital Management first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 4 quarters.
Hood River Capital Management's Ionis Pharmaceuticals position peaked at $7.42M in Q4 2014.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on Hood River Capital Management's 13F filing for Q3 2015, filed 3 Nov 2015.